Impact of the 2025 New South Wales Respiratory Syncytial Virus Prevention Program on Infant Notifications and Hospitalisations: A Population-Based Analysis.
Where this comes from
- Record sourced from PubMed, PMID 42272143.
- Also identified by DOI 10.5694/mja2.70222 and PMC identifier 13254230.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The 2025 NSW RSV Prevention Program, which achieved an estimated coverage of 63% maternal vaccination and 18% for infant immunisation, led to more than 40% reduction in RSV notifications and hospitalisations among infants aged younger than 6 months.
Medical subject headings
- Respiratory Syncytial Virus Infections
- Hospitalization
- Immunization Programs
- Respiratory Syncytial Virus Vaccines